Organogenesis Holdings Inc
ORGO4.606USD
+0.096+2.13%
Market hours （ET）Quotes delayed by 15 min
584.29MMarket Cap
LossP/E TTM
More Details of Organogenesis Holdings Inc Company
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Its advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier and native, cross-linked extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types. Sports Medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for management of open wounds in the surgical setting.
Company Info
Ticker SymbolORGO
Company nameOrganogenesis Holdings Inc
IPO dateDec 02, 2016
CEOMr. Gary S. Gillheeney, Sr.
Number of employees869
Security typeOrdinary Share
Fiscal year-endDec 02
Address85 Dan Rd
CityCANTON
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code02021-2810
Phone17815750775
Websitehttps://investors.organogenesis.com
Ticker SymbolORGO
IPO dateDec 02, 2016
CEOMr. Gary S. Gillheeney, Sr.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Glenn H. Nussdorf
Mr. Glenn H. Nussdorf
Director
Director
11.91M
--
Mr. Patrick Bilbo
Mr. Patrick Bilbo
Chief Operating Officer
Chief Operating Officer
447.51K
-8.12%
Mrs. Lori Freedman, J.D.
Mrs. Lori Freedman, J.D.
Chief Administrative and Legal Officer
Chief Administrative and Legal Officer
419.71K
+150.65%
Mr. Brian Grow
Mr. Brian Grow
Chief Commercial Officer
Chief Commercial Officer
200.53K
-20.89%
Mr. Robert Cavorsi
Mr. Robert Cavorsi
Vice President - Strategy
Vice President - Strategy
189.16K
-0.19%
Mr. Antonio S. Montecalvo
Mr. Antonio S. Montecalvo
Vice President - Health Policy
Vice President - Health Policy
188.20K
+17.78%
Mr. Arthur S. Leibowitz, CPA
Mr. Arthur S. Leibowitz, CPA
Lead Independent Director
Lead Independent Director
187.61K
+0.78%
Ms. Prathyusha Duraibabu, CPA
Ms. Prathyusha Duraibabu, CPA
Independent Director
Independent Director
148.64K
+3.64%
Mr. Jon L. Giacomin
Mr. Jon L. Giacomin
Independent Director
Independent Director
142.62K
+2.31%
Dr. Gilberto Quintero, Ph.D.
Dr. Gilberto Quintero, Ph.D.
Independent Director
Independent Director
140.67K
+1.04%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Glenn H. Nussdorf
Mr. Glenn H. Nussdorf
Director
Director
11.91M
--
Mr. Patrick Bilbo
Mr. Patrick Bilbo
Chief Operating Officer
Chief Operating Officer
447.51K
-8.12%
Mrs. Lori Freedman, J.D.
Mrs. Lori Freedman, J.D.
Chief Administrative and Legal Officer
Chief Administrative and Legal Officer
419.71K
+150.65%
Mr. Brian Grow
Mr. Brian Grow
Chief Commercial Officer
Chief Commercial Officer
200.53K
-20.89%
Mr. Robert Cavorsi
Mr. Robert Cavorsi
Vice President - Strategy
Vice President - Strategy
189.16K
-0.19%
Mr. Antonio S. Montecalvo
Mr. Antonio S. Montecalvo
Vice President - Health Policy
Vice President - Health Policy
188.20K
+17.78%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
By BusinessUSD
Name
Revenue
Proportion
Advanced Wound Care
79.93M
92.20%
Surgical & Sports Medicine
6.77M
7.80%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Advanced Wound Care
79.93M
92.20%
Surgical & Sports Medicine
6.77M
7.80%
Shareholding Stats
Updated: Sat, Jul 12
Updated: Sat, Jul 12
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Soleus Capital Management, L.P.
9.84%
Morgan Stanley & Co. LLC
9.49%
Nussdorf (Glenn H)
9.39%
Ades (Alan A)
8.82%
Erani (Dennis)
7.92%
Other
54.55%
Shareholders
Shareholders
Proportion
Soleus Capital Management, L.P.
9.84%
Morgan Stanley & Co. LLC
9.49%
Nussdorf (Glenn H)
9.39%
Ades (Alan A)
8.82%
Erani (Dennis)
7.92%
Other
54.55%
Shareholder Types
Shareholders
Proportion
Individual Investor
32.52%
Investment Advisor
16.60%
Corporation
14.12%
Investment Advisor/Hedge Fund
13.05%
Hedge Fund
12.78%
Research Firm
10.83%
Sovereign Wealth Fund
0.38%
Pension Fund
0.36%
Bank and Trust
0.06%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
301
127.82M
100.77%
+5.72M
2025Q1
324
125.21M
99.06%
+1.00M
2024Q4
344
121.01M
95.72%
-4.65M
2024Q3
354
109.09M
82.30%
-7.23M
2024Q2
369
107.79M
81.32%
-6.45M
2024Q1
374
102.47M
77.65%
-12.90M
2023Q4
378
102.14M
77.80%
-10.89M
2023Q3
390
113.75M
86.92%
-11.36M
2023Q2
400
112.98M
86.34%
-14.25M
2023Q1
400
117.68M
90.49%
-17.51M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Soleus Capital Management, L.P.
12.48M
9.84%
-6.53K
-0.05%
Mar 31, 2025
Morgan Stanley & Co. LLC
12.03M
9.49%
+286.33K
+2.44%
Mar 31, 2025
Nussdorf (Glenn H)
11.91M
9.39%
--
--
Jun 24, 2025
Ades (Alan A)
11.19M
8.82%
--
--
Jun 24, 2025
Erani (Dennis)
10.04M
7.92%
--
--
Jun 24, 2025
Organo PFG LLC
8.28M
6.53%
--
--
Jun 24, 2025
RED Holdings, L.L.C.
6.78M
5.35%
--
--
Jun 24, 2025
BlackRock Institutional Trust Company, N.A.
4.54M
3.58%
-205.40K
-4.33%
Mar 31, 2025
The Vanguard Group, Inc.
4.43M
3.49%
+841.62K
+23.44%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
3.10M
2.44%
+311.13K
+11.15%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
WisdomTree US SmallCap Fund
0.11%
iShares Micro-Cap ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
Franklin US Small Cap Multifactor Index ETF
0.04%
Avantis US Small Cap Equity ETF
0.03%
Fidelity Enhanced Small Cap ETF
0.03%
iShares Russell 2000 Growth ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 ETF
0.01%
View more
WisdomTree US SmallCap Fund
Proportion0.11%
iShares Micro-Cap ETF
Proportion0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0.05%
Franklin US Small Cap Multifactor Index ETF
Proportion0.04%
Avantis US Small Cap Equity ETF
Proportion0.03%
Fidelity Enhanced Small Cap ETF
Proportion0.03%
iShares Russell 2000 Growth ETF
Proportion0.02%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.02%
Proshares Ultra Russell 2000
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
